Background Ordinary meta‐analyses indicate that magnesium sulphate (MgSO4) treatment
in women at imminent risk for preterm delivery decreases the offspring's risk of cerebral …

Peripheral nerve injury is a common complication in trauma, and regeneration and function
recovery are clinical challenges. It is indispensable to find a suitable material to promote …

Importance Intravenous magnesium sulfate administered to pregnant individuals before birth
at less than 30 weeks' gestation reduces the risk of death and cerebral palsy in their …

Introduction To evaluate the effect of antenatal magnesium sulfate (MgSO4) on mortality and
morbidity outcomes related to the gastrointestinal system (GI) in preterm infants. Methods …

Introduction Over 80% of very preterm (< 32 weeks) and very low birthweight (< 1500 g)
infants will have either typical development (TD) or mild developmental delay (MDD) in …

Background: Antenatal magnesium sulphate (MgSO4) therapy given to women at risk of
preterm birth reduced the risk of cerebral palsy in early childhood. However, its effect on …

BACKGROUND There has been an increasing number of randomized controlled trials
published in obstetrics and maternal-fetal medicine to reduce biases of treatment effect and …

Objective To evaluate the reliability of three artificial intelligence (AI) chatbots (ChatGPT,
Google Bard, and Chatsonic) in generating accurate references from existing obstetric …

Objective To evaluate perinatal survival rates and predictors in severely anemic fetuses that
underwent intrauterine transfusion (IUT). Method This was a retrospective study of both …

Background Antenatal corticosteroids decrease the incidence of severe intraventricular
hemorrhages (grades 3, 4) in preterm infants. It is unclear whether their beneficial effects on …